Bottom line
How much do FBIOX and IBBQ overlap?
33% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 24.2% of FBIOX's assets and 28.7% of IBBQ's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings FBIOX and IBBQ have in common
| Holding | % of FBIOX | % of IBBQ | Overlap |
|---|---|---|---|
| Amgen Inc | 6.53% | 7.10% | 6.53% |
| Gilead Sciences Inc | 4.82% | 7.39% | 4.82% |
| Alnylam Pharmaceuticals Inc | 2.93% | 3.19% | 2.93% |
| Insmed Inc | 2.25% | 1.83% | 1.83% |
| Argenx Se | 2.25% | 1.89% | 1.89% |
| Revolution Medicines Inc | 2.02% | 2.48% | 2.02% |
| Moderna Inc | 1.28% | 1.48% | 1.28% |
| Biogen Inc | 1.26% | 2.29% | 1.26% |
| Bridgebio Pharma Inc | 0.89% | 1.02% | 0.89% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in FBIOX
- Krystal Biotech Inc — 10.58%
- Abbvie Inc — 9.22%
- Fidelity Revere Street Trust — 3.35%
- Praxis Precision Medicines Inc. — 2.47%
- Ascendis Pharma A/s — 2.04%
- Ucb Sa — 2.00%
- Jazz Pharmaceuticals Plc — 1.84%
- Scholar Rock Holding Corp — 1.55%
- Natera Inc — 1.41%
- Axsome Therapeutics Inc — 1.28%
- Protagonist Therapeutics Inc — 1.15%
- Roivant Sciences Ltd — 1.13%
- Cogent Biosciences Inc — 1.07%
- Tango Therapeutics Inc — 0.98%
- Celcuity Inc — 0.95%
Only in IBBQ
- Invesco Private Prime Fund — 14.20%
- Vertex Pharmaceuticals Inc. — 7.38%
- Invesco Private Government Fund — 5.48%
- Regeneron Pharmaceuticals, Inc. — 5.08%
- Illumina, Inc. — 1.98%
- United Therapeutics Corp. — 1.94%
- Royalty Pharma PLC — 1.90%
- Roivant Sciences Ltd. — 1.71%
- Incyte Corp. — 1.53%
- Viatris Inc. — 1.49%
- Guardant Health, Inc. — 1.35%
- Neurocrine Biosciences, Inc. — 1.26%
- Jazz Pharmaceuticals PLC — 1.16%
- Ascendis Pharma A/S — 1.10%
- Summit Therapeutics Inc. — 1.08%
Asset mix
| Asset type | FBIOX | IBBQ |
|---|---|---|
| Stocks | 99.0% | 99.9% |
| Cash & short-term funds | 3.5% | 19.7% |
| Preferred stock | 0.9% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Country mix
| Country | FBIOX | IBBQ |
|---|---|---|
| US | 88.5% | 103.8% |
| NL | 2.9% | 2.5% |
| GB | 0.8% | 2.7% |
| DK | 2.6% | 1.2% |
| BE | 2.0% | — |
| IE | 2.0% | 1.9% |
| BM | 1.1% | 1.7% |
| FR | 0.8% | 1.5% |
Source: SEC Form N-PORT (periods May 31, 2026 / May 31, 2026)
Check another pair
FAQ
How much do FBIOX and IBBQ overlap?
What stocks do FBIOX and IBBQ have in common?
Should I own both FBIOX and IBBQ?
Which holds more stocks, FBIOX or IBBQ?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.